Henderson, Shalom K.
Halai, Ajay
Tsvetanov, Kamen A.
Cope, Thomas E.
Patterson, Karalyn E.
Rowe, James B.
Lambon Ralph, Matthew A.
Funding for this research was provided by:
Gates Cambridge Trust (OPP1144)
Medical Research Council ((MC_UU_00030/14; MR/P01271X/1; MR/T033371/1), (MC_UU_00030/14; MR/P01271X/1; MR/T033371/1), (MC_UU_00030/14; MR/P01271X/1; MR/T033371/1), (MC_UU_00030/14; MR/P01271X/1; MR/T033371/1), (MC_UU_00030/14; MR/P01271X/1; MR/T033371/1))
Alzheimer’s Society (602)
NIHR Cambridge Biomedical Research Centre (BRC-1215-20014; NIHR203312, BRC-1215-20014; NIHR203312, BRC-1215-20014; NIHR203312)
Cambridge Centre for Parkinson-Plus
Wellcome Trust (220258)
Article History
Received: 19 March 2025
Accepted: 28 August 2025
First Online: 30 September 2025
Declarations
:
: For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
: All participants provided written informed consent. Study ethics approval was obtained from the ethics committee at the University of Cambridge (REC#01/8/94).
: The authors declare no competing interests.